US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prospect Capital Corp

25.06

+0.0000

Volume:- -

Turnover:319.71K

Market Cap:9.22B

PE:68.17

High:25.06

Open:25.06

Low:25.06

Close:25.06

Loading ...

Overview Company News Filings

Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors

ACCESS Newswire

Planet Labs PBC Cut to Neutral From Buy by Goldman Sachs

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

ACCESS Newswire

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure

ACCESS Newswire

Is Planet Labs PBC (NYSE:PL) the Best Aerospace and Defense Stock to Buy According to Analyst?

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha

ACCESS Newswire

Planet Labs PBC Price Target Maintained With a $8.00/Share by Needham

Planet Labs PBC: Achieving EBITDA Break-Even and Strategic Growth with JSAT Contract

Cautious Hold Rating for Planet Labs PBC Amid Mixed Financial Signals and Future Uncertainties

Planet Labs PBC Full Year 2025 Earnings: EPS Misses Expectations

Simply Wall St.

Planet Labs PBC Price Target Maintained With a $6.50/Share by Citizens Capital Markets

Planet Labs PBC Price Target Maintained With a $6.30/Share by Cantor Fitzgerald

Analysts Offer Insights on Industrial Goods Companies: Airbus Group SE (OtherEADSF) and Planet Labs PBC (PL)

Deutsche Bank Adjusts Price Target on Planet Labs PBC to $5 From $4.50, Keeps Buy Rating

MT Newswires Live

Cantor Fitzgerald Reaffirms Their Buy Rating on Planet Labs PBC (PL)

JMP Securities Sticks to Its Buy Rating for Planet Labs PBC (PL)

Planet Labs PBC Reports Record Revenue and Growth

Planet Labs PBC (PL) Reports Q4 Loss, Lags Revenue Estimates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"Delisted","change":0,"latestTime":"12-29 16:00:00 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527448587","title":"Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2527448587","media":"ACCESS Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527448587?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:00","pubTimestamp":1744722000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESS Newswire / April 15, 2025 / Tharimmune, Inc. , a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas Capital and Co-Founder of President Street Global, to its Board of Directors, increasing the size of the Board to seven Directors.This appointment strengthens Tharimmune's strategic leadership and will support the company's next phase of growth and product development. It also underscores Tharimmune's commitment to enhancing its leadership team with experienced financial professionals as the company advances key clinical programs, deepens its licensing relationships and builds a pipeline for long-term, sustainable growth.About Vincent LoPrioreMr. LoPriore is a seasoned financial professional with more than 30 years of experience in investment banking, private placements and institutional capital markets. He began his career at Oppenheimer & Co. and sub","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-strengthens-strategic-leadership-appointment-130000133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","THAR","PBC"],"gpt_icon":0},{"id":"2526652889","title":"Planet Labs PBC Cut to Neutral From Buy by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2526652889","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526652889?lang=en_us&edition=fundamental","pubTime":"2025-04-11 18:57","pubTimestamp":1744369020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 06:57 ET (10:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PL","PBC"],"gpt_icon":0},{"id":"2525045971","title":"Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2525045971","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525045971?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESS Newswire / April 7, 2025 / Tharimmune, Inc.  , a clinical-stage biotechnology company focused on immunology and inflammation, today announced preclinical data from its expanded pipeline with HS1940, a dual-target multispecific biologic engineered to bind to both Programmed Death-1  and Vascular Endothelial Growth Factor , and HS3215, a dual-target biologic binding to Human Epidermal Growth Factors 2  and 3  receptors. Using its proprietary EpiClick Technology, a versatile multispecific antibody engineering platform, HS1940 and HS3215 represent a key expansion of Tharimmune's product pipeline and underscores the Company's commitment to addressing unmet needs.HS1940 is designed as a biparatopic  biologic, simultaneously engaging the PD-1 pathway and inhibiting angiogenesis. By using multiple, previously undruggable epitopes on PD-1, and blocking VEGF-mediated tumor vascularization, HS1940 may broaden treatment options and improve outcomes across multiple types of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-announces-positive-data-novel-120000722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["03160","BK4099","THAR","BK4139","BK4604","LU1169589451.USD","LU1169590202.USD","PBC","BK4585","PD","BK4023","TM","BK4555","BK4588"],"gpt_icon":0},{"id":"2524164374","title":"United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2524164374","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524164374?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:00","pubTimestamp":1743609600,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 02, 2025----United Therapeutics Corporation , a public benefit corporation, announced today that Great Place to Work and Fortune magazine recognized the company as one of the Fortune 100 Best Companies to Work For in 2025. United Therapeutics ranked number 73 out of the 100 companies across the nation included in the list.\"We are honored to be recognized by Fortune as one of the 100 Best Companies to Work For,\" said Michael Benkowitz, President & Chief Operating Officer of United Therapeutics. \"This reflects a key management objective that United Therapeutics be a destination employer, where Unitherians can have their best career while fulfilling our mission to help very sick patients through the development of novel therapeutics and progress toward an unlimited supply of transplantable organs.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-therapeutics-named-100-best-160000151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","LU1699723380.USD","BK4532","BK4139","UTHR","LU1571399168.USD"],"gpt_icon":0},{"id":"2523464949","title":"Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2523464949","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523464949?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"-Received positive feedback on New Drug Application submission via the 505 pathway. -Company leveraging existing human pharmacokinetic data with TH104. -Advancing CMC plan to meet requirements of a New Drug Application. \"This feedback from the FDA marks a significant milestone for Tharimmune and for individuals who may face the threat of ultrapotent opioid exposure,\" said Randy Milby, CEO. \"We believe that a rapidly biodegradable buccal film offers prophylactic protection against respiratory distress in such situations represents a crucial advancement. The 505 pathway along with leveraging the established safety and efficacy of the active ingredient, allows us to expedite the development and potential availability of this important product without the need for further clinical trials.\". Specifically, by inputting detailed data from previous human studies conducted by Tharimmune that characterized the PK of the active ingredient via buccal administration as well as existing published da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-announces-positive-fda-feedback-120000749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1363072403.SGD","CNS","IE00BHPRN162.USD","CMC","LU0971096721.USD","BK4181","LU0882574139.USD","IE00B1BXHZ80.USD","LU0267386448.USD","LU0170899867.USD","PK","BK4135","PBC","IE00BKVL7J92.USD","BK4218","IE00BZ1G4Q59.USD","BK4006","LU0149725797.USD","THAR","BK4139"],"gpt_icon":0},{"id":"2523798215","title":"Is Planet Labs PBC (NYSE:PL) the Best Aerospace and Defense Stock to Buy According to Analyst?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523798215","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523798215?lang=en_us&edition=fundamental","pubTime":"2025-03-31 04:58","pubTimestamp":1743368310,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 Best Aerospace and Defense Stocks to Buy According to Analysts. In this article, we are going to take a look at where Planet Labs PBC  stands against other best aerospace and defense stocks to buy according to analysts.On February 13, CNBC reported that President Trump’s statement regarding a potential reduction in US defense spending triggered a drop in defense stocks. During a White House event, the President proposed cutting the defense budget in half, stating that there is no need for the United States to spend nearly $1 trillion on the military. He mentioned plans to discuss this idea with China and Russia in future meetings. This sent mixed signals regarding military spending. On the one hand, he has emphasized the need for a strong military and proposed initiatives like the “Iron Dome of America,” a missile defense system. On the other hand, he also suggested significant cuts to defense spending, aligning with broader efforts to reduce governme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/planet-labs-pbc-nyse-pl-205830172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0006306889.USD","LU0158827781.USD","BK4123","LU0158827948.USD","LU0795875169.SGD","LU0795875086.SGD","BK4127","LU0971096721.USD","BK4516","LU1162221912.USD","LU2111349929.HKD","LU1732800096.USD","LU0912757837.SGD","LU0106261372.USD","NYSE","BK4534","LU1732799900.SGD","LU1074936037.SGD","PBC","LU1668664300.SGD","LU1363072403.SGD","IE00BZ1G4Q59.USD","BK4504","LU1989772923.USD","IE00BKVL7J92.USD","LU2271345857.HKD","LU0106831901.USD","PL","LU1989772840.SGD","BK4588","BK4585","LU2028103732.USD","BK4581","LU2089284900.SGD","LU2089283258.USD","LU2133065610.SGD","LU0267386448.USD","LU2023251221.USD","LU0225283273.USD","LU0098860793.USD","LU1720051108.HKD","LU0314104364.USD","LU2347655156.SGD","LU0320765646.SGD","LU1548497426.USD","LU1720051017.SGD","LU2357305700.SGD"],"gpt_icon":1},{"id":"2522498378","title":"Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2522498378","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522498378?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:30","pubTimestamp":1743071400,"startTime":"0","endTime":"0","summary":"Prospective Multicenter Study Investigates RingerPBC for Management of Coronary Perforations. Ringer PBC is a rapid-exchange percutaneous transluminal coronary angioplasty  catheter with a unique helical balloon. When inflated, the balloon approximates a hollow cylinder with a large central perfusion lumen, allowing for continuous coronary blood flow during prolonged inflations.1. The Ringer PBC study is a limited prospective, multi-center, single-arm IDE study, undertaken at four sites in the United States investigating the RingerPBC for the management of emergent coronary perforations that develop during percutaneous coronary intervention  procedures. The study enrolled 30 participants, and analysis was performed based upon intention-to-treat. The primary efficacy endpoint required successful Ringer PBC delivery and inflation at the perforation site, control of extravasation , and preservation of antegrade coronary flow .\"Teleflex is committed to generating the clinical evidence","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/preliminary-results-ide-study-ringer-103000465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CTO","BK4160","TFX","BK4504","BK4585","PBC","BK4588","BK4082"],"gpt_icon":0},{"id":"2521725882","title":"Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha","url":"https://stock-news.laohu8.com/highlight/detail?id=2521725882","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521725882?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc.  , a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its novel oral antibody, TH023. In a murine model, a proprietary protease enzyme stabilized platform demonstrated successful delivery of infliximab, a tumor necrosis factor-alpha  inhibitor, in serum with concentrations detected being significantly higher than the standard serum trough concentration needed for antibody efficacy in immunology indications via injection . These findings represent a significant step towards developing a more convenient and potentially patient-preferred alternative to currently available infliximab treatments, which are administered via intravenous infusion or subcutaneous injection.The Company announced last year through a partnership with Intract Pharma, an exclusive license to INT-023 (now","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-announces-positive-results-novel-120000890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4218","IBD","PBC","BK4181","THAR","PK"],"gpt_icon":0},{"id":"2521747974","title":"Planet Labs PBC Price Target Maintained With a $8.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747974?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:58","pubTimestamp":1742817480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2025 07:58 ET (11:58 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBC","PL"],"gpt_icon":0},{"id":"2521717448","title":"Planet Labs PBC: Achieving EBITDA Break-Even and Strategic Growth with JSAT Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2521717448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521717448?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:15","pubTimestamp":1742811330,"startTime":"0","endTime":"0","summary":"Needham analyst Ryan Koontz has maintained their bullish stance on PL stock, giving a Buy rating on March 21. Ryan Koontz has given his Buy rating ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/planet-labs-pbc-achieving-ebitda-break-even-and-strategic-growth-with-jsat-contract?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/planet-labs-pbc-achieving-ebitda-break-even-and-strategic-growth-with-jsat-contract?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC"],"gpt_icon":0},{"id":"2521578587","title":"Cautious Hold Rating for Planet Labs PBC Amid Mixed Financial Signals and Future Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2521578587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521578587?lang=en_us&edition=fundamental","pubTime":"2025-03-24 02:15","pubTimestamp":1742753740,"startTime":"0","endTime":"0","summary":"Kristine Liwag, an analyst from Morgan Stanley, maintained the Hold rating on Planet Labs PBC (PL – Research Report). The associated price target i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-for-planet-labs-pbc-amid-mixed-financial-signals-and-future-uncertainties?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-for-planet-labs-pbc-amid-mixed-financial-signals-and-future-uncertainties?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC"],"gpt_icon":0},{"id":"2521985212","title":"Planet Labs PBC Full Year 2025 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2521985212","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521985212?lang=en_us&edition=fundamental","pubTime":"2025-03-22 21:30","pubTimestamp":1742650229,"startTime":"0","endTime":"0","summary":"NYSE:PL Revenue and Expenses Breakdown March 22nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 15%.In the last 12 months, the only revenue segment was Data Processing contributing US$244.4m. The largest operating expense was Research & Development (R&D) costs, amounting to US$97.5m . Explore how PL's revenue and expenses shape its earnings.Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Professional Services industry in the US.The company's shares are down 8.9% from a week ago.Before you take the next step you should know about the 2 warning signs for Planet Labs PBC that we have uncovered.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/planet-labs-pbc-full-2025-133029824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","PL"],"gpt_icon":1},{"id":"2521239517","title":"Planet Labs PBC Price Target Maintained With a $6.50/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2521239517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521239517?lang=en_us&edition=fundamental","pubTime":"2025-03-21 23:37","pubTimestamp":1742571420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 11:37 ET (15:37 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PL","PBC"],"gpt_icon":0},{"id":"2521238489","title":"Planet Labs PBC Price Target Maintained With a $6.30/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2521238489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521238489?lang=en_us&edition=fundamental","pubTime":"2025-03-21 22:33","pubTimestamp":1742567580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 10:33 ET (14:33 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBC","PL"],"gpt_icon":0},{"id":"2521891712","title":"Analysts Offer Insights on Industrial Goods Companies: Airbus Group SE (OtherEADSF) and Planet Labs PBC (PL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521891712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521891712?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:50","pubTimestamp":1742561406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Airbus Group SE (EADSF – Research Report) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-industrial-goods-companies-airbus-group-se-othereadsf-and-planet-labs-pbc-pl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-industrial-goods-companies-airbus-group-se-othereadsf-and-planet-labs-pbc-pl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC","BK4123","PL"],"gpt_icon":0},{"id":"2521285515","title":"Deutsche Bank Adjusts Price Target on Planet Labs PBC to $5 From $4.50, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2521285515","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521285515?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:28","pubTimestamp":1742560082,"startTime":"0","endTime":"0","summary":"Planet Labs PBC (PL) has an average rating of buy and mean price target of $6.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PL","PBC","DB"],"gpt_icon":0},{"id":"2521728829","title":"Cantor Fitzgerald Reaffirms Their Buy Rating on Planet Labs PBC (PL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521728829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521728829?lang=en_us&edition=fundamental","pubTime":"2025-03-21 19:57","pubTimestamp":1742558274,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Colin Canfield from Cantor Fitzgerald maintained a Buy rating on Planet Labs PBC (PL – Research Report), with a pri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-planet-labs-pbc-pl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-planet-labs-pbc-pl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC","PL"],"gpt_icon":0},{"id":"2521401084","title":"JMP Securities Sticks to Its Buy Rating for Planet Labs PBC (PL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521401084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521401084?lang=en_us&edition=fundamental","pubTime":"2025-03-21 13:05","pubTimestamp":1742533541,"startTime":"0","endTime":"0","summary":"In a report released today, Trevor J. Walsh from JMP Securities reiterated a Buy rating on Planet Labs PBC (PL – Research Report), with a price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jmp-securities-sticks-to-its-buy-rating-for-planet-labs-pbc-pl-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jmp-securities-sticks-to-its-buy-rating-for-planet-labs-pbc-pl-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JMP","PBC","PL"],"gpt_icon":0},{"id":"2521444237","title":"Planet Labs PBC Reports Record Revenue and Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2521444237","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521444237?lang=en_us&edition=fundamental","pubTime":"2025-03-21 12:05","pubTimestamp":1742529936,"startTime":"0","endTime":"0","summary":"Planet Labs Pbc ( ($PL) ) has released its Q4 earnings. Here is a breakdown of the information Planet Labs Pbc presented to its investors. Planet L...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/planet-labs-pbc-reports-record-revenue-and-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/planet-labs-pbc-reports-record-revenue-and-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC"],"gpt_icon":0},{"id":"2521418178","title":"Planet Labs PBC (PL) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2521418178","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521418178?lang=en_us&edition=fundamental","pubTime":"2025-03-21 05:25","pubTimestamp":1742505905,"startTime":"0","endTime":"0","summary":"Planet Labs PBC  came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -300%. A quarter ago, it was expected that this company would post a loss of $0.05 per share when it actually produced a loss of $0.02, delivering a surprise of 60%.Planet Labs PBC , which belongs to the Zacks Satellite and Communication industry, posted revenues of $61.55 million for the quarter ended January 2025, missing the Zacks Consensus Estimate by 0.75%. This compares to year-ago revenues of $58.85 million. The company has topped consensus revenue estimates just once over the last four quarters.Planet Labs PBC shares have added about 6.9% since the beginning of the year versus the S&P 500's decline of -3.5%.While Planet Labs PBC has outperformed the market so far this year, the question that comes t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/planet-labs-pbc-pl-reports-212505882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","PL","IRDM"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":145,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000},{"market":"US","date":"2021-05-28","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1622208600000,"name":"Prospect Capital Corp","recordDate":"2021-06-15","payableDate":"2021-06-01","currency":"USD","type":"dividend","dateTimestamp":1622174400000},{"market":"US","date":"2021-02-26","symbol":"PBC","amount":0.4296875,"name":"Prospect Capital Corp","recordDate":"2021-03-15","payableDate":"2021-03-01","currency":"USD","type":"dividend","dateTimestamp":1614315600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{}}}